# Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours

> **NCT01448083** · — · UNKNOWN · sponsor: **Nuclear Medicine Consultants, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Neuroendocrine Tumor

## Interventions

- **OTHER:** Standard of care diagnostic MIBG scan for neuroendocrine tumor diagnosis.

## Key facts

- **NCT ID:** NCT01448083
- **Lead sponsor:** Nuclear Medicine Consultants, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2012-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448083, "Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01448083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*